Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
23 Most Amusing Messages At any point Sent Among Kids and Their Folks - 2Best Food Truck Cooking: Decision in favor of Your Number one!
- 3A Manual for Pick Viable Psychological well-being Backing Administrations In 2024
- 4Grasping the Course of Evacuation and Extradition in U.S. Migration
- 5Grass Care Administrations for a Wonderful, Sound Yard
- Building an Individual Brand: Illustrations from Powerhouses
- Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment
- Foot fossil discovery could reshape human evolutionary history
- 6 Exercises to Anticipate in 2024
- DEA seizes 1.7 million counterfeit fentanyl pills in Colorado storage unit
- A top Marine shares his secrets to keeping fit at 50
- 6 Home Cleaning Administrations to Keep Your Home Unblemished
- Gaza Strip sees flooding after heavy rainfall
- Party Urban areas of the World
